Roche Could Pay $2B In Deal To Develop Potent Cancer Drugs
By Gianna Ferrarin · January 4, 2024, 7:20 PM EST
Moma Therapeutics announced Thursday that it could receive over $2 billion in milestone payments from Swiss pharmaceutical giant Roche through a new collaboration to develop powerful cancer treatments....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login